SANOFISANOFISANOFI

SANOFI

No trades
See on Supercharts

Key facts today

Vir Biotechnology licensed three T-cell engager programs for cancer treatment from Sanofi, enhancing its oncology and infectious disease efforts.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.67 T‬MXN
‪99.16 B‬MXN
‪790.89 B‬MXN
‪2.51 B‬
Beta (1Y)
0.30
Employees (FY)
‪87.99 K‬
Change (1Y)
‪−3.58 K‬ −3.91%
Revenue / Employee (1Y)
‪529.17 K‬MXN
Net income / Employee (1Y)
‪66.35 K‬MXN

About SANOFI


CEO
Paul Hudson
Headquarters
Paris
Website
Founded
1994
FIGI
BBG00JX0P7G1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
SANOFI SA 18/28
Yield to maturity
4.54%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.12%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
2.90%
Maturity date
Mar 21, 2034
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.76%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.76%
Maturity date
Apr 6, 2029
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.71%
Maturity date
Mar 21, 2029
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.71%
Maturity date
Mar 21, 2030
FR1332434
SANOFI 18/26 MTN
Yield to maturity
2.65%
Maturity date
Mar 21, 2026
FR1214680
SANOFI 14/26 MTN
Yield to maturity
2.65%
Maturity date
Sep 10, 2026
FR1320163
SANOFI 16/27 MTN
Yield to maturity
2.54%
Maturity date
Jan 13, 2027
FR1296903
SANOFI 15/25 MTN
Yield to maturity
2.53%
Maturity date
Sep 22, 2025

Explore more bonds 

Frequently Asked Questions


The current price of SNY/N is 1,071.00 MXN — it has increased by 0.04% in the past 24 hours. Watch SANOFI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange SANOFI stocks are traded under the ticker SNY/N.
SNY/N stock has fallen by −2.32% compared to the previous week, the month change is a −2.32% fall, over the last year SANOFI has showed a 31.22% increase.
We've gathered analysts' opinions on SANOFI future price: according to them, SNY/N price has a max estimate of 1,372.97 MXN and a min estimate of 982.51 MXN. Watch SNY/N chart and read a more detailed SANOFI stock forecast: see what analysts think of SANOFI and suggest that you do with its stocks.
SNY/N stock is 0.66% volatile and has beta coefficient of 0.30. Track SANOFI stock price on the chart and check out the list of the most volatile stocks — is SANOFI there?
Today SANOFI has the market capitalization of ‪2.66 T‬, it has increased by 3.28% over the last week.
Yes, you can track SANOFI financials in yearly and quarterly reports right on TradingView.
SANOFI is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SNY/N net income for the last half-year is ‪44.53 B‬ MXN, while the previous report showed ‪36.19 B‬ MXN of net income which accounts for 23.03% change. Track more SANOFI financial stats to get the full picture.
Yes, SNY/N dividends are paid annually. The last dividend per share was 24.83 MXN. As of today, Dividend Yield (TTM)% is 2.80%. Tracking SANOFI dividends might help you take more informed decisions.
SANOFI dividend yield was 2.97% in 2023, and payout ratio reached 63.38%. The year before the numbers were 2.84% and 39.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 2, 2024, the company has ‪87.99 K‬ employees. See our rating of the largest employees — is SANOFI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANOFI EBITDA is ‪274.23 B‬ MXN, and current EBITDA margin is 30.09%. See more stats in SANOFI financial statements.
Like other stocks, SNY/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANOFI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANOFI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANOFI stock shows the buy signal. See more of SANOFI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.